Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong financial performance with record-high core income and underwriting gains, coupled with a solid dividend yield. While there are some concerns about rate changes and medical inflation, the company seems to be managing these effectively. The Q&A section highlights positive sentiment from analysts, with management providing satisfactory answers to most queries. Overall, the positive financial metrics and shareholder returns are likely to drive a positive stock price movement in the short term.
Core Income (Q4 2023) $362 million, up 37% year-over-year due to strong underwriting performance and increased net investment income.
Net Investment Income (Q4 2023) $611 million pretax, up $108 million (21%) from the prior year, driven by contributions from both alternatives and fixed income portfolios.
P&C Core Income (Q4 2023) $434 million, up $92 million (27%) year-over-year, reflecting strong underwriting gains.
All-in Combined Ratio (Q4 2023) 92.1%, improved by 1.6 points year-over-year, due to benign catastrophe losses and favorable prior period development.
Underlying Combined Ratio (Q4 2023) 91.4%, consistent with the previous year, marking the 12th consecutive quarter below 92%.
Underlying Loss Ratio (Q4 2023) 59.9%, consistent with Q4 2022, indicating stable loss trends.
Expense Ratio (Q4 2023) 31.2%, slightly up from last year, attributed to higher employee-related costs.
Gross Written Premium Growth (Q4 2023) 10% growth in gross written premium ex-captives, consistent with strong production performance.
Net Written Premium Growth (Q4 2023) 10% growth, reflecting strong retention and favorable pricing.
Core Income (Full Year 2023) $1.3 billion or $4.71 per share, up 54% year-over-year, driven by increased investment returns and record P&C underwriting gains.
P&C Core Income (Full Year 2023) $1.5 billion, up 21% year-over-year, reflecting strong underwriting performance.
Pretax Underwriting Gain (Full Year 2023) $585 million, a record high, contributing to overall profitability.
All-in Combined Ratio (Full Year 2023) 93.5%, with a record-low underlying combined ratio of 90.9%, marking seven consecutive years of improvement.
Gross Written Premium Growth (Full Year 2023) 10% growth ex-captives, indicating strong market performance.
Net Written Premium Growth (Full Year 2023) 9% growth, reflecting strong retention and pricing.
Operating Cash Flow (Q4 2023) $520 million, reflecting strong underwriting results and investment income.
Stockholders' Equity (Year-end 2023) $12.6 billion, up 10% from year-end 2022, indicating strong capital position.
Dividend Increase (Q4 2023) Regular quarterly dividend increased by 5% to $0.44 per share, reflecting strong financial performance.
Special Dividend (Q4 2023) Declared a special dividend of $2 per share, indicating confidence in ongoing profitability.
New Business Growth: New business growth was 16%, the highest it's been all year, driven by Commercial, capitalizing on strong pricing and an excellent pipeline of new business opportunities.
Core Income: Core income increased by $97 million in the fourth quarter to a record $362 million.
Dividend Increase: CNA announced a 5% increase in the regular quarterly dividend from $0.42 to $0.44 per share and a special dividend of $2 per share.
Gross Written Premium Growth: Gross written premium ex-captive growth was double digit for the quarter and for the full year, representing the third consecutive year of double-digit growth.
Renewal Premium Change: Renewal premium change was 5% in the quarter, down 1 point from the prior quarter.
Pricing Environment: Lines of business impacted by social inflation saw rate increases accelerate, with excess casualty rates up double digits in Q4.
Combined Ratio Improvement: The all-in combined ratio improved to 92.1%, a decrease of 1.6 points compared to the prior year quarter.
Expense Ratio: The expense ratio of 31.2% was up slightly from last year.
Investment Income Growth: Net investment income before tax increased 21% for the quarter.
Focus on Underwriting Performance: CNA achieved record underlying and all-in underwriting gains for the full year.
Conservative Approach to New Business: CNA remains prudent on new business in management liability lines until the competitive environment improves further.
Social Inflation Impact: The company has noted elevated loss cost trends due to social inflation, particularly affecting lines such as commercial auto and general liability. This trend has led to increased pricing pressures, which the company expects to continue.
Regulatory and Legal Risks: The company faces risks related to adverse development in prior accident years, particularly for general liability, as court backlogs clear and new claim information emerges. This could lead to increased reserve strengthening.
Supply Chain Challenges: The company has indicated challenges in the management liability lines due to a competitive environment, which has led to fewer new opportunities and a cautious approach to new business.
Economic Factors: The company anticipates that economic conditions will continue to influence underwriting performance and investment income, particularly in light of fluctuating interest rates and market dynamics.
Expense Management: The company has experienced higher employee-related costs, including incentive compensation and legacy pension plan costs, which could impact future expense ratios.
Reinsurance Market Dynamics: While the company reported favorable reinsurance renewals, there is a risk of minor movements in ceding commissions and capacity that could affect future profitability.
Gross Written Premium Growth: Gross written premium ex-captive growth was double digit for the quarter and for the full year, representing the third consecutive year of double-digit growth.
Core Income: Core income increased by $97 million in the fourth quarter to a record $362 million.
New Business Growth: New business growth was 16%, the highest it's been all year, driven by Commercial.
Retention Rate: Retention remained high at 85% this quarter, up 1 point compared to last quarter.
Dividend Increase: CNA announced a 5% increase in the regular quarterly dividend from $0.42 to $0.44 per share and a special dividend of $2 per share.
2024 Investment Income Expectations: Expect income from fixed income and other investments to be about $2.150 billion for 2024.
2024 Effective Tax Rate: Expect full year 2024 effective tax rate to be about 21%.
2024 Expense Ratio: Continue to believe an expense ratio of 31% is a reasonable run rate for 2024.
Pricing Environment: Expect renewal pricing to keep pace with loss cost trends as we move into 2024.
Overall Outlook: Expect to continue leveraging profitable growth opportunities in 2024.
Regular Quarterly Dividend: CNA is increasing its regular quarterly dividend by 5% from $0.42 per share to $0.44 per share.
Special Dividend: CNA is declaring a special dividend of $2 per share.
Dividend Payment Date: Both dividends will be paid on March 7, 2024, to shareholders of record on February 20, 2024.
Dividend Yield: CNA shares have a dividend yield of 8.7%, inclusive of the $2 special dividend.
Share Buyback Program: None
Despite strong core income and underwriting results, the company faces challenges from competitive pressures, declining rates, and uncertainties in loss cost trends. While the dividend and investment income are positives, these are counterbalanced by risks in the LTC portfolio and social inflation impacts. The Q&A section did not provide additional clarity, leaving the overall sentiment neutral.
The earnings call indicates strong financial performance with record core income, increased net investment income, and stable combined ratios. The Q&A session highlighted a favorable market outlook and strategic focus on specialty underwriting, although uncertainties around PFAS exposures were noted. Dividend increases and strong cash flow further support positive sentiment. Despite some challenges in international and specialty segments, overall growth and profitability signals suggest a positive stock price movement.
The earnings call indicates strong financial performance with record-high core income and underwriting gains, coupled with a solid dividend yield. While there are some concerns about rate changes and medical inflation, the company seems to be managing these effectively. The Q&A section highlights positive sentiment from analysts, with management providing satisfactory answers to most queries. Overall, the positive financial metrics and shareholder returns are likely to drive a positive stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.